AMACR is not useful in the differential diagnosis between papillary renal cell carcinoma and TFE3-rearranged renal cell carcinoma since both tumors are usually labeled for this marker, but it helps distinguish from TFEB-rearranged renal cell carcinoma. This evidence concerns the gene TFEB and renal cell carcinoma.